跳至主要内容
临床试验/PACTR201505001076143
PACTR201505001076143Other未知

IMPACT OF MORINGA OLEIFERA SUPPLEMENTATION ON BODY MASS INDEX AND IMMUNE RESPONSE OF HIV-PATIENTS UNDER ANTIRETROVIRAL THERAPY A SINGLE BLIND RANDOMIZED CLINICAL TRIA

Public Health School, Université Libre de Brussels0 个研究点目标入组 0 人开始时间: 2015年3月17日最近更新:
适应症

试验速览

阶段
未知
状态
Other
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Year(s) 至 60 Year(s)(—)
性别
All

入选标准

  • the patients included in the study had 18 years old above, treated with ART, at clinical stages 2 and 3 or 4 according to WHO classification but stabilied (without opportunisctic affection upon inclusion in the study). Without renal dysfunction, without adverse symptoms of malabsorption (digestive i.d without diarrhea in the three weeks preceding the beginning of study), and with a stable weight curve tree going months preceding the intervention study.

排除标准

  • were excluded from study pregnant women patients and patient who were in stages 1,2 ,3 and 4 but not stabilized, as welle as those who did attend not consent, or who did not attend the consultation. In addition to those with renal dysfunction.

研究者

发起方
Public Health School, Université Libre de Brussels

相似试验